Prostate cancer with metastasis — Lutetium 177-PSMA (LU-177)
Clinic of Advanced Biological Medicine
The Clinic of Advanced Biological Medicine in Frankfurt am Main aims to boost the immune system, to maintain and improve the quality of life in case of disease, minimize side effects of toxic treatment, to increase chances for recovery as well as to increase life span through the use of effective treatments.
Lutetium 177 PSMA (LU-177) radionuclide therapy for men with prostate cancer
➤Prostata Cancer Treatment with Lutetium 177-PSMA ★ Direct prices from the best hospitals in the world $ We will help you save money on treatment ✔ Patient support 24/7
Treatment prices are regulated by national law of the corresponding countries, but can also include additional hospital coefficients. In order to receive the individual cost calculation, please send us the request and medical records.
The Department of Nuclear Medicine annually provides treatment to more than 620 patients with metastatic prostate cancer. During the therapy a high-quality radioactive lutetium isotope (Lu-177) preparation is used. Lu-177 specifically bounds to the PSMA-containing tumor cells and metastases and kills them. Doctors of the department under the guidance of Prof. Dr. med. S. Ezziddin offer effective treatment with a minimal complications rate.
people Interpreter up to 12 hours
list Translation up to 10 pages
card_membership Visa support
book Insurance against increased costs in case of complications with a cover of 200,000 €
The Department of Nuclear Medicine at the University Hospital Carl Gustav Carus Dresden is distinguished due to ist high professional competence in the field of diagnosis and treatment by open radionuclides. The treatment by open radionuclides has been provided in the Department since 1970. The most common treatment form is thyroid radioiodine therapy.
University Hospital of Ludwig Maximilian University of Munich
Department of Nuclear Medicine
The Department of Nuclear Medicine offers the full range of diagnostic and therapeutic services in modern nuclear medicine for both outpatients and inpatients. The focus is on the detection and treatment of oncological, neurological and cardiac diseases. The department is the largest institution of this kind in Germany. The international recognition is approved by ISO 9001: 2015 certification.
The Department of Nuclear Medicine offers the full range of services in this field. The key clinical focuses include the diagnosis and treatment of tumors, thyroid, kidney, brain and heart diseases. To do this, doctors have at their disposal all the necessary medical equipment of the latest generation, for example, devices for PET-CT, SPECT/CT, MRI, etc.
The Department of Nuclear Medicine at the University Hospital of Würzburg provides all diagnostic and therapeutic procedures with the use of open radioactive sources. The Department has 14 special beds for medical care. There are annually treated over 1,300 patients.
The Department of Nuclear Medicine at the University Hospital Muenster offers all diagnostic and treatment options in the field of nuclear medicine at the highest medical and technical level. The Department specializes in the treatment of thyroid cancer and different oncological diseases. The Department is headed by Prof. Dr. med. Michael Schäfers.
The Department of Nuclear Medicine at the University Hospital Erlangen offers the entire spectrum of diagnostic and therapeutic methods in this field. The special innovative focuses include PET/CT, SPECT/CT and innovative therapeutic methods of nuclear medicine, such as peptide radio-receptor therapy for neuroendocrine tumors, radioembolization of liver tumors and prostate cancer treatment with the use of radioligands to the Prostate-Specific-Membrane-Antigen (PSMA).
The Department of Nuclear Medicine at the University Hospital of Halle (Saale) offers not only common and proven types of scintigraphic diagnosis and treatment, due to the use of an effective radiochemotherapy, but also such methods as SPECT/CT and PET/CT with various tracers and current radiopharmaceuticals. The Department is headed by Dr. med. Andreas Odparlik, specialist in nuclear medicine and diagnostic radiology.
The Department of Nuclear Medicine at the Essen University Hospital performs numerous tasks in the diagnosis and treatment of the entire field of nuclear medicine. With the appropriate recommendations, the Department carries out all radioisotope examinations. A particular attention is given to the diagnosis (and treatment) of thyroid, especially care of patients with thyroid cancer, the diagnosis and treatment of endocrine tumors, as well as myocardial, skeletal scintigraphy and radioisotope examinations in childhood.
The Department of Nuclear Medicine at the University Medical Center Hamburg-Eppendorf offers its patients the entire spectrum of modern radioisotope diagnosis. The peculiarities of the Department include the so-called multimodal methods that involve procedures carried out simultaneously with computer tomography. To carry out PET/CT, the Department has innovative radiopharmaceuticals for the examination of patients with prostate cancer and neuroendocrine tumors.
Department of Nuclear Medicine and Clinical Imaging Diagnosis
The Department of Nuclear Medicine and Clinical Imaging Diagnosis at the University Hospital Tubingen offers a wide range of services in the field of innovative nuclear medicine and molecular diagnosis. The medical director of the Deparment is Prof. Dr. med. Christian la Fougère. Through the use of radioactive marked drugs (as well as radioactive indicators developed in the University Hospital Tubingen), there is carried out an effective targeted therapy since the applied radiation has a minimal depth of penetration.
The Department of Nuclear Medicine offers the entire spectrum of radioisotope diagnosis and radionuclide therapy. In the field of imaging diagnosis, the department is equipped with the state-of-the-art two-chamber systems of single-photon emission computed tomography (SPECT) in its all three units, including a few hybrid SPECT/CT – systems of innovative construction, as well as the advanced PET/CT – (PET: positron emission tomography) systems with the Time-of-Flight function for the highest image quality.
The Department of Nuclear Medicine offers the full range of radioisotope diagnostics and treatment of various diseases. The department is equipped with the advanced medical equipment, which provides the most accurate scanning of all anatomical structures and organs of the human body. In the field of treatment, the focus is on oncological, cardiological and neurological diseases. The department's doctors work in accordance with the international standards, therefore, each patient receives high-quality, individualized medical care.
The Department of Nuclear Medicine under the direction of Prof. Dr. med. Felix M. Mottaghy offers all currently available diagnostic and therapeutic methods of nuclear medicine. All modern therapy types of nuclear medicine are carried out in the nuclear therapy ward with 6 beds. They include radioiodine therapy for the treatment of benign and malignant diseases of thyroid, peptide receptor radionuclide therapy (PRRT), selective internal radiotherapy (SIRT) and radioimmunotherapy.
The Department of Nuclear Medicine offers the entire range of diagnosis and treatment in the field of nuclear medicine. The main objective of the department is to achieve the highest possible diagnostic result and treatment effect with a minimal strain exerted on the patient.
The Department of Nuclear Medicine at the University Hospital Dusseldorf has an outpatient clinic of nuclear medicine with the entire spectrum of scintigraphy varying from diagnosis of thyroid and skeleton and up to the exchange of amino acids in case of brain tumors and diagnosis of metabolism at other malignant oncological diseases. The head of the Department is Prof. Dr. med. H.-W. Müller.